Genetic Polymorphism and Post Operative Nausea and Vomiting (PONV) (ponv)
Genetic Polymorphism Associated With the Occurrence of Postoperative Vomiting and Vomiting (PONV) in Patients Undergoing Oncological Surgeries
Sponsor: Fundação de Amparo à Pesquisa do Estado de São Paulo
This observational or N/A phase trial investigates Genetic Predisposition to Disease and Polymorphism, Genetic and is currently completed. Fundação de Amparo à Pesquisa do Estado de São Paulo leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jun 2021 — Dec 2021 [monthly]
Completed
Status: Recruiting → Completed
▶ Show 4 earlier versions
-
Jan 2021 — Jun 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2020 — Nov 2020 [monthly]
Recruiting
-
Sep 2018 — Jun 2020 [monthly]
Recruiting
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Instituto do Cancer do Estado de São Paulo
For direct contact, visit the study record on ClinicalTrials.gov .